3.6. Safety of MED-01 and Placebo
A total of 101 randomized participants (50 in the MED-01 group and 51 in the placebo group) who consumed MED-01 or placebo capsules at least once were analyzed (The vital signs (pulse and blood pressure) and body weight of all subjects were found to be within the normal ranges in both the groups. In addition, there were no significant difference in inspection parameters, including hematology, blood chemistry, and urinalysis between the two groups after 12 weeks.